{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:54:47Z","timestamp":1759938887031},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1157\/13093983","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T04:05:53Z","timestamp":1161835553000},"page":"1058-1069","source":"Crossref","is-referenced-by-count":4,"title":["Tratamiento hormonal sustitutivo y enfermedades cardiovasculares"],"prefix":"10.1016","volume":"59","author":[{"given":"Nanette K.","family":"Wenger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13093983_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cct.2005.09.010","article-title":"Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene","volume":"26","author":"Wenger","year":"2005","journal-title":"Contemporary Clinical Trials"},{"key":"10.1157\/13093983_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1157\/13093983_bib6","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa030311","article-title":"Effect of estrogen plus progestin on health-related quality of life","volume":"348","author":"Hays","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13093983_bib7","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: A randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib8","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women. The Women's Health Initiative Memory Study: A randomized controlled trial","volume":"289","author":"Rapp","year":"2003","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib9","unstructured":"US Food and Drug Administration FDA Updates: hormone therapy information for postmenopausal women [accedido 28 Oct 2004). Disponible en: www.fda.gov\/bbs\/topic\/NEWS\/2004\/NEW01022.html."},{"key":"10.1157\/13093983_bib10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy. Scientific review","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib11","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-137-10-200211190-00013","article-title":"Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1157\/13093983_bib12","first-page":"4","article-title":"Review of the evidence on the long-term safety of HRT","volume":"30","year":"2004","journal-title":"Curr Probl Pharmacovigilance"},{"key":"10.1157\/13093983_bib13","unstructured":"The European Agency for the Evaluation of Medicinal Products EMEA public statement on recent publications regarding hormone replacement therapy. 3 December 2003. Disponible en: http:\/\/www.emea.eu.int\/index\/indexh1.htm."},{"key":"10.1157\/13093983_bib14","first-page":"975","article-title":"The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: The Minnesota Heart Survey (2000-2002). J Women\u2019?","volume":"13","author":"Barber","year":"2004","journal-title":"Health"},{"key":"10.1157\/13093983_bib15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib16","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.288.19.2432","article-title":"Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial","volume":"288","author":"Waters","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2004.09.021","article-title":"Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial","volume":"179","author":"Kelemen","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1157\/13093983_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000134955.93951.D5","article-title":"Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance","volume":"110","author":"Howard","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13093983_bib19","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(02)12001-0","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1157\/13093983_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women","volume":"349","author":"Hodis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1157\/13093983_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.CIR.0000114834.85476.81","article-title":"Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women","volume":"109","author":"Mosca","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13093983_bib22","article-title":"Hormone replacement therapy for preventing cardiovascular disease in postmenopausal women","volume":"1","author":"Gabriel-S\u00e1nchez","year":"2006","journal-title":"The Cochrane Collaboration"},{"key":"10.1157\/13093983_bib23","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ajog.2003.09.045","article-title":"Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause","volume":"190","author":"Brownley","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1157\/13093983_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13697130400001372","article-title":"Cardiovascular risk factors in middle-aged women and the association with use of hormone therapy: results from a population-based study of Swedish women. The Women's Health in the Lund Area (WHILA) Study","volume":"7","author":"Shakir","year":"2004","journal-title":"Climacteric"},{"key":"10.1157\/13093983_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cardiores.2004.12.012","article-title":"Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen","volume":"66","author":"Dubey","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1157\/13093983_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archinte.164.5.482","article-title":"Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women. Results from 2 large clinical trials","volume":"164","author":"Lobo","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1157\/13093983_bib27","first-page":"507","article-title":"Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting","volume":"32","author":"Nussmeier","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"10.1157\/13093983_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/07853890410035430","article-title":"Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?","volume":"36","author":"Mikkola","year":"2004","journal-title":"Ann Med"},{"key":"10.1157\/13093983_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09513590410001729888","article-title":"Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk","volume":"18","author":"Cerquetani","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1157\/13093983_bib30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.amjcard.2004.07.153","article-title":"Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women","volume":"94","author":"Da Costa","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1157\/13093983_bib31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/j.0001-6349.2004.00217.x","article-title":"Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study","volume":"83","author":"Chang T-","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1157\/13093983_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.ATV.0000199248.53590.e1","article-title":"Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women","volume":"26","author":"Lamon-Fava","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1157\/13093983_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08037050510008788","article-title":"Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension","volume":"14","author":"Karalis","year":"2005","journal-title":"Blood Pressure"},{"key":"10.1157\/13093983_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopsycho.2004.11.004","article-title":"Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women","volume":"69","author":"Matthews","year":"2005","journal-title":"Biol Psychol"},{"key":"10.1157\/13093983_bib35","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1160\/TH04-09-0608","article-title":"Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study","volume":"93","author":"Langer","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1157\/13093983_bib36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjcard.2003.11.019","article-title":"Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen\/progestin combinations, and nonusers","volume":"93","author":"Husak","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1157\/13093983_bib37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","article-title":"Association between hormone replacement therapy and subsequent stroke: a meta-analysis","volume":"330","author":"Bath","year":"2005","journal-title":"BMJ"},{"key":"10.1157\/13093983_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ajog.2004.08.017","article-title":"Estrogen therapy and risk of cognitive decline: Results from the Women's Estrogen for Stroke Trial (WEST)","volume":"192","author":"Viscoli","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1157\/13093983_bib39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.WNL.0000115171.46508.19","article-title":"Statin use and stroke outcomes in the Heart and Estrogenprogestin Replacement Study (HERS)","volume":"62","author":"Bushnell","year":"2004","journal-title":"Neurology"},{"key":"10.1157\/13093983_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/er.2004-0014","article-title":"Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's Health Initiative","volume":"26","author":"Wise","year":"2005","journal-title":"Endocrine Reviews"},{"key":"10.1157\/13093983_bib41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1474-4422(05)70220-9","article-title":"Oestrogen and stroke in women: assessment of risk","volume":"4","author":"Bushnell","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1157\/13093983_bib42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-136-9-200205070-00011","article-title":"Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force","volume":"136","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1157\/13093983_bib43","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib44","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","volume":"112","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"10.1157\/13093983_bib45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective casecontrol study","volume":"3","author":"Douketis","year":"2005","journal-title":"J Thromb Haemast"},{"key":"10.1157\/13093983_bib46","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1157\/13093983_bib47","first-page":"395","article-title":"Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?","volume":"12","author":"Douketis","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1157\/13093983_bib48","first-page":"863","article-title":"for the SYMPHONY and 2nd SYMPHONY Investigators Postmenopausal hormone use in women with acute coronary syndromes. J Women\u2019?","volume":"13","author":"Parsons","year":"2004","journal-title":"Health"},{"key":"10.1157\/13093983_bib49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.CIR.0000115309.63979.92","article-title":"Estrogen plus progestin and the risk of peripheral arterial disease. The Women's Health Initiative","volume":"109","author":"Hsia","year":"2004","journal-title":"Circulation"},{"key":"10.1157\/13093983_bib50","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.ASN.0000119574.27772.FD","article-title":"Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen\/progestin Replacement Study (HERS)","volume":"15","author":"O\u2019Hare","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1157\/13093983_bib51","first-page":"325","article-title":"for the WISE Study Group Hormone replacement, race, and psychological health in women: A report from the NHLBI-sponsored WISE Study. J Women\u2019?","volume":"13","author":"Olson","year":"2004","journal-title":"Health"},{"key":"10.1157\/13093983_bib52","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/jc.2003-030324","article-title":"Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women","volume":"89","author":"Kirwan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13093983_bib53","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.amjmed.2005.03.004","article-title":"The effect of hormone replacement on physical performance in community-dwelling elderly women","volume":"118","author":"Greenspan","year":"2005","journal-title":"Am J Med"},{"key":"10.1157\/13093983_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00042192-200512010-00009","article-title":"Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study","volume":"12","author":"Barrett-Connor","year":"2005","journal-title":"Menopause"},{"key":"10.1157\/13093983_bib55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archinte.165.5.510","article-title":"Hormone therapy, lipoprotein subclasses, and coronary calcification. The Healthy Women Study","volume":"165","author":"Mackey","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1157\/13093983_bib56","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1111\/j.1540-8159.2005.00041.x","article-title":"Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens","volume":"28","author":"Fernandes","year":"2005","journal-title":"PACE"},{"key":"10.1157\/13093983_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10286-005-0295-2","article-title":"The effect of hormone replacement therapy cessation on heart rate variability in postmenopausal women","volume":"15","author":"Weissman","year":"2005","journal-title":"Clin Auton Res"},{"key":"10.1157\/13093983_bib58","first-page":"366","article-title":"Estrogen and progestin use and the QT interval in postmenopausal women","volume":"9","author":"Kadish","year":"2004","journal-title":"ANE"},{"key":"10.1157\/13093983_bib59","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0002-9149(02)02835-7","article-title":"Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial","volume":"90","author":"Wenger","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1157\/13093983_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"Engl J Med"},{"key":"10.1157\/13093983_bib61","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.ATV.0000133683.65877.bc","article-title":"Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women","volume":"24","author":"Koh","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1157\/13093983_bib62","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2004.04846.x","article-title":"Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers","volume":"124","author":"Stevenson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1157\/13093983_bib63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00042192-200512020-00013","article-title":"Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women","volume":"12","author":"Crisafulli","year":"2005","journal-title":"Menopause"},{"key":"10.1157\/13093983_bib64","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinte.161.9.1161","article-title":"A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy","volume":"161","author":"Glazier","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1157\/13093983_bib65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/eurheartj\/ehi311","article-title":"Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, crossover study","volume":"26","author":"Koh","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1157\/13093983_bib66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief Report: Coronary heart disease events associated with hormone therapy in younger and older woman. A meta-analysis","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1157\/13093983_bib67","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/aje\/kwi223","article-title":"Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative Clinical Trial","volume":"162","author":"Prentice","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1157\/13093983_bib68","first-page":"35","article-title":"Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation. J Women\u2019?","volume":"15","author":"Grodstein","year":"2006","journal-title":"Health"},{"key":"10.1157\/13093983_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500042417","article-title":"KEEPS: The Kronos Early Estrogen Prevention Study","volume":"8","author":"Harman","year":"2005","journal-title":"Climacteric"}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893206747534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893206747534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T21:05:00Z","timestamp":1555880700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300893206747534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0300893206747534"],"URL":"https:\/\/doi.org\/10.1157\/13093983","relation":{},"ISSN":["0300-8932"],"issn-type":[{"value":"0300-8932","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}